Hugel Aesthetics

Hugel Aesthetics is the international aesthetics business and U.S.-headquartered division of South Korea-based Hugel focused on commercializing injectable medical aesthetics products in markets including the United States, Canada, Australia, and New Zealand. Its portfolio centers on Letybo (letibotulinumtoxinA) for glabellar lines and a broader facial injectable offering that includes hyaluronic acid fillers supplied through its relationship with Croma-Pharma. The company positions itself as a commercial-stage medical aesthetics organization combining Korean-developed neurotoxin products with filler and related aesthetic offerings. It operates as part of the broader Hugel group, which develops, manufactures, and distributes botulinum toxin, fillers, skin boosters, threads, and other aesthetic products globally.